1. Home
  2. OBIO vs REA Comparison

OBIO vs REA Comparison

Compare OBIO & REA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orchestra BioMed Holdings Inc.

OBIO

Orchestra BioMed Holdings Inc.

HOLD

Current Price

$5.43

Market Cap

253.9M

Sector

Health Care

ML Signal

HOLD

Logo Rare Earths Americas Inc. Common Stock

REA

Rare Earths Americas Inc. Common Stock

N/A

Current Price

$13.45

Market Cap

232.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
OBIO
REA
Founded
2017
N/A
Country
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Metal Mining
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
253.9M
232.3M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
OBIO
REA
Price
$5.43
$13.45
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$14.25
N/A
AVG Volume (30 Days)
274.5K
109.7K
Earning Date
05-11-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
33.13
N/A
EPS
N/A
N/A
Revenue
$33,482,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.43
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1169.22
N/A
52 Week Low
$2.20
$8.95
52 Week High
$5.78
$17.84

Technical Indicators

Market Signals
Indicator
OBIO
REA
Relative Strength Index (RSI) 75.80 51.74
Support Level $4.07 $10.92
Resistance Level N/A $15.82
Average True Range (ATR) 0.29 1.02
MACD 0.15 0.32
Stochastic Oscillator 82.11 64.54

Price Performance

Historical Comparison
OBIO
REA

About OBIO Orchestra BioMed Holdings Inc.

Orchestra BioMed Holdings Inc is a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships with medical device companies. The company's flagship product candidates are Atrioventricular Interval Modulation Therapy (AVIM Therapy) for the treatment of hypertension, the risk factor for death, and Virtue Sirolimus AngioInfusion Balloon (Virtue SAB) for the treatment of atherosclerotic artery disease, the cause of mortality. It has one reportable segment, which consists of the development of clinical and preclinical product candidates through risk-reward sharing partnerships with medical device companies.

About REA Rare Earths Americas Inc. Common Stock

Rare Earths Americas Inc is an exploration stage company focused on advancing projects related to rare earth minerals. Its activities include evaluating mineralization and assessing the characteristics and economic potential of its assets. Its portfolio includes the Shiloh Project in Georgia, United States; the Alpha Project in Bahia, Brazil; and the Constellation Project in Minas Gerais, Brazil. It also holds additional early-stage exploration projects, including the Homer Project in Goiás, Brazil, and the Liberty Peak Project in Georgia, United States. The company has two reportable segments due to their geographical location: United States Mining Operations and Brazil Mining Operations.

Share on Social Networks: